Skip to content

Osteopathic Manipulative Treatment in Oncology Patients' Management

Pain and Quality of Life Management in Oncology Geriatric Patients With Osteopathic Manipulative Treatment: a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03142386
Enrollment
23
Registered
2017-05-05
Start date
2015-09-30
Completion date
2016-03-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric Oncology, Osteopathy in Other Diseases Classified Elsewhere

Keywords

geriatric oncology, pain, osteopathic manipulative treatment, quality of life

Brief summary

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comparison trial was performed in Unit of Oncology Rehabilitation, Palazzolo Institute, Don Carlo Gnocchi Foundation ONLUS, Milan, Italy, from September 2015 to March 2016. 23 older oncology patients were unrolled and allocated in two experimental groups: study group (OMT group, N=12) underwent to osteopathic manipulative treatment associated to physiotherapy and control group (PT group, N = 11) underwent only physiotherapy. At enrollment (T0), 23 recruited oncology patients completed the socio-demographic forms and were evaluated, from external examiner, pain intensity and quality of life. All patients were revaluated at the end of treatment (T4) for quality of life and every week (T1, T2, T3 and T4) for pain intensity. Standard level of significance was p\<0.05.

Interventions

OTHEROsteopathic manipulative treatment
OTHERPhysiotherapy

Sponsors

Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* oncology patients * male and female * age≥65 years * with a clinical prognosis of 6-24 months * diagnosis of multifactorial hyperkinetic syndrome (i.e. metastatic surgery) * pain intensity score higher than 3, measured with Numeric Rating Scale (NRS)

Exclusion criteria

* patients were receiving chemotherapy or radiotherapy treatment at the time of the study * with mental disorders (MMSE\<10) * the presence of infection * anticoagulation therapy * cardiopulmonary disease * clinical instability post-surgery.

Design outcomes

Primary

MeasureTime frameDescription
PainOnce a week for a total 4 weeksNumeric Rating Scale (NRS) is a validated scale to measure the intensity of pain, with numbers between 0 and 10, with 0 representing absence of pain and 10 the worst possible pain experienced by the patient.

Secondary

MeasureTime frameDescription
Quality of lifeAt baseline and up to 4 weeks.European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQC30) is a validated multidimensional health-related quality of life (HRQOL) questionnaire composed of six functional scales, three symptom scales, and several additional single item scales.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026